This innovation enhances viral stability, preserves potency, and reduces allergic reactions and antigen crystallisation-related issues
This marks the second indication for which gumokimab has gained NDA review acceptance
The partnership initially will focus on cardiovascular and kidney diseases
The goal of the agreement is to advance cell and gene therapy accessibility by enabling scalable and efficient cell therapy manufacturing
Iktos will deploy its AI-driven tools to accelerate the identification of optimized small-molecule candidates against a currently undisclosed oncology target
The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of June 10, 2026
The grant will fund ten new J.MD projects over the next three years, targeting multiple global health threats
Collaboration funds participating biotechs to access Lilly predictive models through the Revvity Signals Xynthetica offering
DengiAll will be the first indigenous single-shot dengue vaccine in India and is expected to enter the markets by 2027
It is currently the only vaccine authorized by the Drug Controller General of India (DCGI) for active immunization against HEV in adults aged 18 to 65
Subscribe To Our Newsletter & Stay Updated
